Empower Women Change the World
Evofem develops and markets products that are woman-controlled, non-invasive and rapidly reversible. Women need access to effective products that are well suited to their lifestyle and consistent with their core values.
Evofem, Inc. Submits New Drug Application to U.S. FDA for Amphora™ as a Contraceptive
July 6, 2015
San Diego, CA – Evofem, Inc. announced today that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for approval of Amphora as a contraceptive vaginal gel for women. The submission is based on the results of a large, multicenter, open-label, randomized, phase III trial that examined the…